Institute of Cancer and Genomic Sciences Using fundamental research and the power of genomics to develop better therapies in cancer and other complex diseases.
News TREATWolfram clinical trial to unlock a potential treatment for a rare disease Birmingham is making a real-world impact on rare diseases, with a comprehensive multi-facility network for research helping to find new treatments for patients like those with Wolfram syndrome.
News Stopping the awakening of sleeping Acute Myeloid Leukaemia stem cells to prevent disease relapse
News Cancer Research UK Clinical Trials Unit: Celebrating 40 Years of Funding From Cancer Research UK
QS World University Subject Rankings released for 2023 University of Birmingham rises 30 places to be joint 62nd in the world for Life Sciences and Medicine.
10 February 2023 Scientists reveal the genetic code controlling the development of blood cells from stem cells New study uncovers the information encoded in our DNA required for the transcriptional control of blood cell development from embryonic stem cells
16 January 2023 Experimental cancer therapy research continues at Birmingham New and innovative ways to detect and treat cancer being trialled at Birmingham are to receive renewed funding from Cancer Research UK and the NIHR.
08 December 2022 Birmingham researcher wins three major awards to work on DNA repair Across 2022, Professor Jo Morris, from the Institute of Cancer and Genomics, has secured more than £4.9 million to better understand DNA replication and repair.
08 December 2022 MDS colleagues celebrate receiving MRC clinical fellowships Two University of Birmingham researchers have been awarded prestigious Medical Research Council (MRC) clinical fellowships this year.
11 November 2022 Rare cancer treatment changed thanks to major clinical trial Children and adult with a rare form of bone cancer are receiving a new standard of treatment that is more effective, thanks to a CRCTU clinical trial.
27 October 2022 How chameleon cancers can change their colors to survive treatment Some leukemias evade treatment by changing their appearance and identity through changing the read-out of their DNA, a new study has found.